HBK Sorce Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $592K | Buy |
|
|||||
|
2025
Q2 | $451K | Sell |
|
|||||
|
2025
Q1 | $470K | Buy |
|
|||||
|
2024
Q4 | $404K | Buy |
|
|||||
|
2024
Q3 | $415K | Sell |
|
|||||
|
2024
Q2 | $401K | Sell |
|
|||||
|
2024
Q1 | $431K | Buy |
|
|||||
|
2023
Q4 | $395K | Buy |
|
|||||
|
2023
Q3 | $304K | Buy |
|
|||||
|
2023
Q2 | $343K | Sell |
|
|||||
|
2023
Q1 | $316K | Sell |
|
|||||
|
2022
Q4 | $631K | Buy |
|
|||||
|
2022
Q3 | $304K | Buy |
|
|||||
|
2022
Q2 | $210K | Buy |
|
|||||
|
2022
Q1 | $227K | Buy |
|
|||||
|
2021
Q4 | $263K | Buy |
|
|||||
|
2021
Q3 | $295K | Sell |
|
|||||
|
2021
Q2 | $326K | Buy |
|
|||||
|
2021
Q1 | $325K | Buy |
|
|||||
|
2020
Q4 | $306K | Buy |
|
|||||
|
2020
Q3 | $231K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $224K | Buy |
|
|||||
|
2018
Q2 | $218K | Buy |
|